An isolated transposase AG-TEF11 and uses thereof

CN120591233BActive Publication Date: 2026-08-28BEIJING ASTRAGENOMICS TECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202510735313.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2023-03-27
Filing Date
2024-03-12
Publication Date
2026-08-28
Estimated Expiration
2044-03-12

AI Technical Summary

Technical Problem

尽管转座子已被证实广泛存在于从原核到真核的各个领域中,但是在进化过程中,为了保持基因组的稳定性,有大量的转座子片段变为沉默失活

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120591233B_ABST
    Figure CN120591233B_ABST
Patent Text Reader

Abstract

An isolated transposase and uses thereof are provided. Also provided are nucleic acids and nucleic acid constructs encoding the transposase, nucleic acid panels and nucleic acid panel constructs, compositions, recombinant vectors, recombinant host cells and kits comprising the transposase. Also provided are a method for introducing an exogenous nucleic acid fragment into a genome of a host cell, a method for editing a genome of a host cell and a method for obtaining a host cell containing an exogenous nucleic acid fragment in a genome. Also provided are uses of the transposase, nucleic acids and nucleic acid constructs, nucleic acid panels and nucleic acid panel constructs, compositions, recombinant vectors or recombinant host cells for introducing an exogenous nucleic acid fragment gene into a genome of a host cell or for preparing a medicament or a preparation for gene therapy, cell therapy, genomic research or stem cell induction and post-induction differentiation.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Replicative transposon system

    CN109072258A

  • Method for detecting T cell activation degree of antibody drug taking CD3 as target

    CN112458149A